Glenmark Pharmaceuticals Ltd
company logo

Glenmark Pharmaceuticals Ltd

ParticularsSep 2026Jun 2026Mar 2026
Revenue2,584.012,773.402,454.45
Operating Expense1,936.951,821.742,483.80
Net Profit434.89735.64-73.90
Net Profit Margin16.83%26.52%-3.01%
Earning Per Share15.4126.07-2.62
EBIDTA632.57934.054.14
Effective Tax Rate16.03%11.86%-0%
Particulars
Revenue2,584.01
Operating Expense1,936.95
Net Profit434.89
Net Profit Margin16.83
Earning Per Share15.41
EBIDTA632.57
Effective Tax Rate16.03